Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Østrup Jensen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
British Journal of Cancer|February 3, 2017
High folic acid diet enhances tumour growth in PyMT-induced breast cancerMariann Fagernæs Hansen, Sarah Østrup Jensen, Ernst-Martin Füchtbauer, et al.
Epigenetics|May 31, 2017
Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNAMai-Britt Worm Ørntoft, Sarah Østrup Jensen, Thomas Birkballe Hansen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2024
Second Primary Lung Cancer - An Emerging Issue in Lung Cancer SurvivorsSarah Østrup Jensen, David A Moore, Arif A Surani, et al.
International Journal of Cancer|December 15, 2020
Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancerMai-Britt Worm Ørntoft, Sarah Østrup Jensen, Nadia Øgaard, et al.
International Journal of Molecular Sciences|April 27, 2024
Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNAAmanda Frydendahl, Mads Heilskov Rasmussen, Sarah Østrup Jensen, et al.
Cells|June 4, 2020
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker PotentialMarianne Trier Bjerre, Maibritt Nørgaard, Ole Halfdan Larsen, et al.
NPJ Precision Oncology|January 21, 2026
Preoperative positive ctDNA analysis is associated with the tumor microenvironment, and the risk of recurrence in non-metastatic colorectal cancerMikail Gögenur, Lukas Balsevicius, Sarah Østrup Jensen, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 5, 2024
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancerCecilie Riis Iden, Salah Mohammad Mustafa, Nadia Øgaard, et al.
Clinical Epigenetics|November 16, 2019
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation studySarah Østrup Jensen, Nadia Øgaard, Mai-Britt Worm Ørntoft, et al.
Science Advances|July 10, 2026
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencingHaichao Wang, Paulius D Mennea, Grainne McAndrew, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
British Journal of Cancer|February 3, 2017
High folic acid diet enhances tumour growth in PyMT-induced breast cancerMariann Fagernæs Hansen, Sarah Østrup Jensen, Ernst-Martin Füchtbauer, et al.
Epigenetics|May 31, 2017
Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNAMai-Britt Worm Ørntoft, Sarah Østrup Jensen, Thomas Birkballe Hansen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2024
Second Primary Lung Cancer - An Emerging Issue in Lung Cancer SurvivorsSarah Østrup Jensen, David A Moore, Arif A Surani, et al.
International Journal of Cancer|December 15, 2020
Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancerMai-Britt Worm Ørntoft, Sarah Østrup Jensen, Nadia Øgaard, et al.
International Journal of Molecular Sciences|April 27, 2024
Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNAAmanda Frydendahl, Mads Heilskov Rasmussen, Sarah Østrup Jensen, et al.
Cells|June 4, 2020
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker PotentialMarianne Trier Bjerre, Maibritt Nørgaard, Ole Halfdan Larsen, et al.
NPJ Precision Oncology|January 21, 2026
Preoperative positive ctDNA analysis is associated with the tumor microenvironment, and the risk of recurrence in non-metastatic colorectal cancerMikail Gögenur, Lukas Balsevicius, Sarah Østrup Jensen, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 5, 2024
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancerCecilie Riis Iden, Salah Mohammad Mustafa, Nadia Øgaard, et al.
Clinical Epigenetics|November 16, 2019
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation studySarah Østrup Jensen, Nadia Øgaard, Mai-Britt Worm Ørntoft, et al.
Science Advances|July 10, 2026
A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencingHaichao Wang, Paulius D Mennea, Grainne McAndrew, et al.
Pageof 2